Drug utilization evaluation of Piperacillin/Tazobactam in a tertiary care teaching hospital

HealthMED

Volumn 4, Issue 4 SUPPL. 1, 2010, Pages 1044-1055

  Ismail, Mohammad ^a   Iqbal, Zafar ^a   Hammad, Muhammad ^b   Ahsan, Salwa ^b   Sheikh, Abdul Latif ^b   Asim, Syed Muhammad ^a   Khan, Tahir Mehmood ^c  

^a UNIVERSITY OF PESHAWAR   (Pakistan)

^b AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

^c KING FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Broad spectrum penicillins; Drug use evaluation; Quality improvement; Rational use of antibiotics

Indexed keywords

EID: 79851498706     PISSN: 18402291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Achong M, Hauser B, and Krusky J (1977) Rational and irrational use of antibiotics in a Canadian teaching hospital. Canadian Medical Association Journal. 116, 256-259
2. Askarian M, Assadian O, Safaee G, Golkar A, Namazi S, and Movahed M (2007) Vancomycin use in a large teaching hospital in Shiraz, Islamic Republic of Iran, 2003. Eastern Mediterranean Health Journal. 13, 1195-1201
3. Bassetti M, Di Biagio A, Rebesco B, Cenderello G, Amalfitano M, and Bassetti D (2000) Impact of an antimicrobial formulary and restriction policy in the largest hospital in Italy. International Journal of Antimicrobial Agents. 16, 295-299
4. Belongia E, and Schwartz B (1998) Strategies for promoting judicious use of antibiotics by doctors and patients. British Medical Journal. 317, 668-671
5. Cirioni O, Ghiselli R, Kamysz W, Orlando F, Silvestri C, Mocchegiani F, Di Matteo F, Kamysz E, Riva A, and Rocchi M (2007) Tachyplesin III and granulocyte-colony stimulating factor enhance the efficacy of tazobactam/piperacillin in a neutropenic mouse model of polymicrobial peritonitis. Peptides. 29, 31-38
6. Cizman M, Srovin T, Pokorn M, Cad Pecar S, and Battelino S (2005) Analysis of the causes and consequences of decreased antibiotic consumption over the last 5 years in Slovenia. J Antimicrob Chemother. 55, 758-763
7. Drummond CWE (2006) Resistance is futile--a conference to promote the rational use of antimicrobials in acute hospitals. J Antimicrob Chemother. 57, 171-175
8. Dunagan W (1989) Antimicrobial misuse in patients with positive blood cultures. The American Journal of Medicine. 87, 253-259
9. Erbay A, Bodur H, AkInc I E, and Çolpan A (2005) Evaluation of antibiotic use in intensive care units of a tertiary care hospital in Turkey. Journal of Hospital Infection. 59, 53-61
10. Erbay A, Çolpan A, Bodur H, Çevik MA, Samore MH, and Ergönül Ö (2003) Evaluation of antibiotic use in a hospital with an antibiotic restriction policy. International Journal of Antimicrobial Agents. 21, 308-312
11. Goldmann D, Weinstein R, Wenzel R, Tablan O, Duma R, Gaynes R, Schlosser J, and Martone W (1996) Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA. 275, 234-240
12. Gyssens I (2001) Quality measures of antimicrobial drug use. International Journal of Antimicrobial Agents. 17, 9-19
13. Hammerman A, Greenberg A, and Yinnon A (1997) Drug use evaluation of ciprofloxacin: impact of educational efforts on appropriateness of use. Journal of Clinical Pharmacy and Therapeutics. 22, 415-420
14. Holloway K, and Green T (2003) Tools to investigate the use of medicines. In: Holloway K (ed). Drug and therapeutics committees: A practical guide. Department of Essential Drugs and Medicines Policy, World Health Organization, Geneva, Switzerland, 71-94
15. Ibrahim K, Gunderson B, and Rotschafer J (2001) Intensive care unit antimicrobial resistance and the role of the pharmacist. Critical care medicine. 29, N108
16. Kunin C (1993) Resistance to antimicrobial drugs-- a worldwide calamity. Annals of internal medicine. 118, 557-561
17. Levy S (1991) Antibiotic availability and use: consequences to man and his environment. Journal of clinical epidemiology. 44, 83S
18. Levy SB (2002) Factors impacting on the problem of antibiotic resistance. J Antimicrob Chemother. 49, 25-30
19. Lode H (2008) Rational antibiotic therapy and the position of ampicillin/sulbactam. International Journal of Antimicrobial Agents. 32, 10-28
20. Miller L, Ratnam K, and Payne D (2001) Beta- Lactamase-inhibitor combinations in the 21st century: current agents and new developments. Current Opinion in Pharmacology. 1, 451-458
21. Natsch S, Steeghs MHM, Hekster YA, Meis JFGM, van der Meer JWM, and Kullberg BJ (2001) Use of fluconazole in daily practice: still room for improvement. J Antimicrob Chemother. 48, 303-310
22. Nys S, Okeke IN, Kariuki S, Dinant GJ, Driessen C, and Stobberingh EE (2004) Antibiotic resistance of faecal Escherichia coli from healthy volunteers from eight developing countries. J Antimicrob Chemother. 54, 952-955
23. O'Brien T (1997) The global epidemic nature of antimicrobial resistance and the need to monitor and manage it locally. Clinical Infectious Diseases. 24, 2-8
24. Perry C, and Markham A (1999) Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections. Drugs. 57, 805-843
25. Phillips M, Gayman J, and Todd M (1996) ASHP guidelines on medication-use evaluation. American Society of Health-system Pharmacists. American Journal of Health-System Pharmacy. 53, 1953-1955
26. Raveh D, Muallem-Zilcha E, Greenberg A, Wiener- Well Y, Schlesinger Y, and Yinnon A (2006) Prospective drug utilization evaluation of three broad-spectrum antimicrobials: cefepime, piperacillin- tazobactam and meropenem. QJMed. 99, 397- 406
27. Roark M, and Reed Jr W (1995) Econotherapeutics. Diagnostic Microbiology and Infectious Disease. 22, 209-217
28. Schentag J, Ballow C, Fritz A, Paladino J, Williams J, Cumbo T, Ali R, Galletta V, Gutfeld M, and Adelman M (1993) Changes in antimicrobial agent usage resulting from interactions among clinical pharmacy, the infectious disease division, and the microbiology laboratory. Diagnostic Microbiology and Infectious Disease. 16, 255-264
29. Senn L, Burnand B, Francioli P, and Zanetti G (2004) Improving appropriateness of antibiotic therapy: randomized trial of an intervention to foster reassessment of prescription after 3 days. J Antimicrob Chemother. 53, 1062-1067
30. Shah B, and Shah V (2004) Antimicrobial used by the department of obstetrics and gynecology of tertiary care hospital: analysis for rationality and other aspects. J Obstet Gynecol Ind. 54, 387-392
31. Speirs GE, Fenelon LE, Reeves DS, Speller DCE, Smyth EG, Wilcox MH, and MacGowan AP (1995) An audit of ciprofloxacin use in a District General Hospital. J Antimicrob Chemother. 36, 201-207
32. Thomas M, Govil S, Moses B, and Joseph A (1996) Monitoring of antibiotic use in a primary and a tertiary care hospital. Journal of Clinical Epidemiology. 49, 251-254
33. Thuong M, Shortgen F, Zazempa V, Girou E, Soussy CJ, and Brun-Buisson C (2000) Appropriate use of restricted antimicrobial agents in hospitals: the importance of empirical therapy and assisted re-evaluation. J Antimicrob Chemother. 46, 501- 508
34. Tornøe C, Tworzyanski J, Imoisili M, Alexander J, Korth-Bradley J, and Gobburu J (2007) Optimising piperacillin/tazobactam dosing in paediatrics. International Journal of Antimicrobial Agents. 30, 320-324
35. Tünger Ö, Dinç G, Özbakkaloglu B, Atman ÜC, and Algün Ü (2000) Evaluation of rational antibiotic use. International Journal of Antimicrobial Agents. 15, 131-135
36. van Kasteren MEE, Kullberg BJ, de Boer AS, Mintjes- de Groot J, and Gyssens IC (2003) Adherence to local hospital guidelines for surgical antimicrobial prophylaxis: a multicentre audit in Dutch hospitals. J Antimicrob Chemother. 51, 1389-1396
37. von Gunten V, Troillet N, Beney J, Boubaker K, Luthi J-C, Taffe P, and Reymond J-P (2005) Impact of an interdisciplinary strategy on antibiotic use: a prospective controlled study in three hospitals. J Antimicrob Chemother. 55, 362-366
38. Wilson M, and Peterson A (1999) Drug Utilization Review Strategies. In: Navarro R (ed). Managed Care Pharmacy Practice. Aspen Publisher Inc.: Gaithersburg, Maryland, 167-184
39. Yang Y, Kao S, and Chan K (1997) A retrospective drug utilization evaluation of antihyperlipidaemic agents in a medical centre in Taiwan. Journal of Clinical Pharmacy and Therapeutics. 22, 291-299
40. Yilmaz G, Bulut C, Yildiz F, Arslan S, Yetk N M, and Dem Röz A (2009) Examining Antibiotic Use at an Education and Research Hospital in Turkey: Point Prevalence Results. Turk J Med Sci. 39, 125-131
41. Yinnon A, Skorohod Y, Schlesinger Y, and Greenberg A (2000) Cefuroxime utilization evaluation: impact of physician education on prescribing patterns. The Israel Medical Association Journal. 2, 187-191
42. Ziglam HM, Elliott I, Wilson V, Hill K, and Nathwani D (2005) Clinical audit of linezolid use in a large teaching hospital. J Antimicrob Chemother. 56, 423-426
43. Mahmutović-Vranic, S., Rebic, V.Significance of single antibiotic susceptibility tests in routine use diagnostics of streptococci upper respiratory tract infections HealthMED 2009; 3(2): 155-158